genprowebdirectory
GEN Edge
Featured News
Multimedia
News
Insights
Topics
Artificial Intelligence
Bioprocessing
Cancer
Drug Discovery
Genome Editing
Infectious Diseases
OMICs
Translational Medicine
Magazine
Current Issue
Past Issues
Supplements
Subscribe
Multimedia
Summits
Webinars
GEN Live
Learning Labs
Podcasts
Resources
eBooks/Perspectives
Tutorials
Peer-Reviewed Journals
GEN Biotechnology
Re:Gen Open
New Products
Conference Calendar
Subscribe
Get GEN Magazine
Get GEN eNewsletters
Search
Sign in
Welcome! Log into your account
your username
your password
Forgot your password? Get help
Privacy Policy
Password recovery
Recover your password
your email
A password will be e-mailed to you.
GEN – Genetic Engineering and Biotechnology News
GEN Edge
Featured News
Multimedia
News
Insights
Topics
Artificial Intelligence
Bioprocessing
Cancer
Drug Discovery
Genome Editing
Infectious Diseases
OMICs
Translational Medicine
Magazine
Current Issue
Past Issues
Supplements
Subscribe
Multimedia
Summits
Webinars
GEN Live
Learning Labs
Podcasts
Resources
eBooks/Perspectives
Tutorials
Peer-Reviewed Journals
GEN Biotechnology
Re:Gen Open
New Products
Conference Calendar
Subscribe
Get GEN Magazine
Get GEN eNewsletters
Latest
All
More
Drug Discovery
After Mod 2.0, What Can Be Done to Boost Adoption of Alternatives to Animal Models?
Bioprocessing
BPI News: Primrose Bio Blossoms from Pelican and Primordial Genetics Merger
Drug Discovery
StockWatch: Abcam Founder Opposes $5.7B Danaher Acquisition
Drug Discovery
Can CRISPR Crack the Code to Treating HIV Infections?
Artificial Intelligence
Generate:Biomedicines Raises Largest Biotech Series C of 2023
Artificial Intelligence
Chemify to Dream Up and Deliver Drugs for Dewpoint Therapeutics
Drug Discovery
Lights, Camera: Actio Biosciences Launches to Bridge Common and Rare Disease Treatments
Artificial Intelligence
Shuttle Launch: Cellares’ Smart Factories Aim to Meet Cell Therapy Demand at Global Scale
Artificial Intelligence
Superluminal Medicines Launches to Drug Protein Conformations in a Flash
OMICs
StockWatch: Investors, Analysts Debate Background of New Illumina CEO
OMICs
StockWatch: Despite 3-Week Decline, PacBio Stock Doubles in a Year
Close to the Edge
Perfect Pitch: Genome Editing Pioneer Fyodor Urnov on Commercializing CRISPR Therapies and Epigenomic Tuning
GEN Edge
Lessons from the Minimal Cell
Artificial Intelligence
Schrödinger’s Equation: Physics + Machine Learning = Drug Discovery
OMICs
StockWatch: Illumina Results Leave Investors, Analysts Anxious
Drug Discovery
StockWatch: Regeneron’s All Ears for Hearing Loss Drug Developer
Artificial Intelligence
Ordaōs Uses AI to Generate Therapeutic Mini-Proteins
Genome Editing
Frequency Change: Korro Bio Edits Its Message, Rewrites Its Future with Reverse Merger
Drug Discovery
Solu Therapeutics Launches with $31 Million to Unlock Cell-Surface Targets
Drug Discovery
StockWatch: Apellis Shares Nosedive 73% on Safety Concerns
Summits
The State of Biotech 2023
Drug Discovery
StockWatch: Layoffs Extend Biogen’s Stock Skid
Drug Discovery
Trier Bryant Pairs 82VS with Alloy to Create Asset-Centric Companies
OMICs
StockWatch: Quantum-Si Surges 47% as ARK Raises Its Stake
Artificial Intelligence
StockWatch: After $50M from Nvidia, Investors Bullish on Recursion
Artificial Intelligence
Boston Calling: Genomenon Acquires Boston Genetics for Rapid Human Genome Curation
Artificial Intelligence
Verily Rolling Along: Google’s Life-Sci Sister Doubles Down on AI
Infectious Diseases
AGT Spins Out Addimmune, Focusing on Functional HIV Cure
Genome Editing
StockWatch: Caribou Shares Surge on $25M Pfizer Investment
Drug Discovery
StockWatch: Abcam, Founder Spar over Company’s Future
Load more
Scroll Up
